SCHEMBL25850063

SCHEMBL25850063

Cc1ccc(C(F)(F)F)cc1C(=O)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS2R14 Q9NYV8 2/20 0.52
PTGS2 P35354 1/20 0.51
SRD5A2 P31213 2/20 0.50
CNR2 P34972 2/20 0.47
GAA P10253 1/20 0.47
P2RX1 P51575 1/20 0.46
CES2 O00748 2/20 0.46
CNR1 P21554 1/20 0.46
KCNK3 O14649 1/20 0.46
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
HPGD P15428 2/20 0.44
GLA P06280 1/20 0.44
KDM4E B2RXH2 1/20 0.44
USP2 O75604 1/20 0.44
ALDH1A1 P00352 1/20 0.44
CYP2C19 P33261 1/20 0.44
HSD17B10 Q99714 1/20 0.44
LMNA P02545 1/20 0.44
SORT1 Q99523 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28672497 0.85 TDP1 (0.58) PTGS2SRD5A2NPC1RAB9AGLA
SCHEMBL12360588 0.83 PTGS2 (0.47) PTGS2CNR2CES2CNR1ALDH1A1
SCHEMBL9537242 0.82 KDM4E (0.62) TAS2R14SRD5A2CNR2P2RX1CES2
SCHEMBL5992479 0.82 CNR2 (0.55) SRD5A2CNR2GAAP2RX1CES2
SCHEMBL30070755 0.82 CNR2 (0.55) SRD5A2CNR2GAAP2RX1CES2
SCHEMBL29941444 0.82 SRD5A2 (0.51) SRD5A2CNR2P2RX1CES2CNR1
SCHEMBL3660770 0.82 SRD5A2 (0.51) SRD5A2CNR2P2RX1CES2CNR1
SCHEMBL3486347 0.82 MAPT (0.61) SRD5A2CNR2GAAP2RX1CES2
SCHEMBL710431 0.81 TAS2R14 (0.59) TAS2R14CES2HPGDKDM4EUSP2
SCHEMBL27353325 0.81 GLA (0.55) SRD5A2CNR2P2RX1CES2CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227409-A1 QUINOLINONE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS IDEAYA BIOSCIENCES, INC. 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227409-A1 QUINOLINONE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS MAT2B, MAT2A, MAT1A TAS2R14 4392/4885PTGS2 1085/4885SRD5A2 1441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.